Eris Lifesciences Limited appoints Mr. Rajeev Dalal as an Additional Independent Director

Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of Eris Lifesciences Limited have passed a circular resolution on December 19, 2020, approving appointment of Mr. Rajeev Dalal (DIN : 00222650) as an "Additional Director (Non‐Executive Independent Director)" on the Board of Directors of the Company with effect from December 19, 2020 for a term of 5 (five) years upto December 18, 2025, subject to approval of the Shareholders of the Company.

Profile Summary of Mr. Rajeev Dalal: Mr. Rajeev Dalal is a Member of the Institute of Company Secretaries of India. Further he also holds degree of Bachelor of Law and Bachelor of Commerce. He has also been a member of the Committee appointed by the Securities Exchange Board of India (SEBI) for improving disclosure standards in public documents of Corporates for Capital issues. He has over 35 years of Corporate Finance experience covering 100+ M&A (domestic and cross border) transactions and Private Equity deals in sectors such as Pharma, Chemicals, FMCG, Metals & Mining, Industrials and Financial Services. He was associated with Ernst & Young LLP as transactions partner in 2002, prior to that he was associated with Ind Global Finance Trust (a category 1 investment bank), HSBC and JM Financial in their investment banking divisions.

Mr. Rajeev Dalal is not related to any other existing Director of the Company and is not debarred from holding the office by virtue of any SEBI Order or any other authority.

Shares of Eris Lifesciences Ltd was last trading in BSE at Rs.567 as compared to the previous close of Rs. 564.95. The total number of shares traded during the day was 9498 in over 716 trades.

The stock hit an intraday high of Rs. 574.9 and intraday low of 550. The net turnover during the day was Rs. 5351715.

Source : Equity Bulls

Keywords